Helping to Drive Discovery in 23andMe’s Therapeutics Division

September 21, 2021
Xin Fang’s interest in science started at the dinner table, listening to her parents talking about what they did each day. Both her mom and dad are plant scientists. Her mom...
Read More

Talking About Rare Disease with Senior Scientist Suyash Shringarpure

September 14, 2021
23andMe senior scientist in statistical genetics, Suyash Shringarpure, Ph.D. talks about 23andMe's research model and how it offers a surprising opportunity in the study of rare diseases.
Read More

23andMe and GSK Begin First Clinical Trial with Cancer Therapy

July 29, 2020
A drug to fight cancer will be the first potential therapy to emerge from 23andMe and GlaxoSmithKline collaboration as the two companies announced that the new therapy will begin clinical trials.
Read More

Meet 23andMe’s Head of Therapeutics Kenneth Hillan

June 12, 2019
23andMe's Head of Therapeutics Kenneth Hillan, M.B., Ch.B., discussed his career and the vision for 23andMe's work in therapeutics
Read More

23andMe at Annual Meeting of the American Society of Human Genetics

October 15, 2018
More than 50 23andMe scientists will be participating in the annual meeting of the American Society of Human Genetics in San Diego this year.
Read More

A Note On 23andMe’s New Collaboration with GSK

July 25, 2018
23andMe announces the launch of a collaboration with GlaxoSmithKline (GSK) to accelerate our ability to make meaningful discoveries in therapeutics to treat disease.
Read More

23andMe’s CEO Featured On The Today Show

October 17, 2016
As part of a series on cutting edge women, The Today Show featured Anne Wojcicki, 23andMe’s CEO and co-founder. The NBC crew followed Anne as she hustled through a typical...
Read More

23andMe Scientists To Present New Findings at ASHG

October 06, 2016
23andMe scientists will be at the annual American Society of Human Genetics meeting in Vancouver this month sharing a wide spectrum of interesting data that includes more on the genetics...
Read More

23andMe And Drug Discovery

October 28, 2015
The sobering fact about drug development is that it takes too long and costs too much money. 23andMe wants to change all that. At the annual meeting of the American...
Read More

Richard Scheller Named to National Academy of Medicine

October 19, 2015
Growing up 23andMe’s chief science officer Richard Scheller, Ph.D., had classmates in his elementary school, who wanted to be a firemen, police officers and astronauts.Richard always wanted to be a...
Read More